Quest Diagnostics Incorporated (DGX) Stock Analysis
Range Bound setup
Healthcare · Diagnostics & Research
Sell if holding. At $192.73, A.R:R 0.7:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Negative momentum; Thin upside margin: 4.2%.
Quest Diagnostics provides diagnostic testing services to approximately one-third of the US adult population annually, serving physicians, hospitals, patients, health plans, and employers. Generated $11.0B in revenue in 2025 from clinical lab testing and related services.
Sell if holding. At $192.73, A.R:R 0.7:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Negative momentum; Thin upside margin: 4.2%. Chart setup: RSI 50 mid-range, Bollinger mid-band. Score 5.2/10, moderate confidence.
Passes 5/7 gates (clean insider activity, no SEC red flags, news events none recent, earnings proximity 81d clear, semi cycle peak clear). Fails on weak momentum and favorable risk/reward ratio. Suitability: moderate.
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- MEDIUMSupplierthird-party billing operations10-K Item 1A: 'The majority of billing and related operations for our Company are being provided by a third party under the Company’s oversight.'
Material Events(8-K, last 90d)
- 2026-03-12Item 5.02LOWBoard elected Timothy Wentworth (former CEO of Walgreens Boots Alliance) as director on March 9, 2026. Added to Compensation and Quality/Compliance Committees.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
1 floor-breaker
Momentum below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. At $192.73, A.R:R 0.7:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Negative momentum; Thin upside margin: 4.2%. Chart setup: RSI 50 mid-range, Bollinger mid-band. Prior stop was $181.88. Score 5.2/10, moderate confidence.
Take-profit target: $200.81 (+4.2% upside). Prior stop was $181.88. Stop-loss: $181.88.
Thin upside margin: 4.2%; Negative momentum.
Quest Diagnostics Incorporated trades at a P/E of 21.5 (forward 16.7). TrendMatrix value score: 6.1/10. Verdict: Sell.
24 analysts cover DGX with a consensus score of 3.8/5. Average price target: $223.
What does Quest Diagnostics Incorporated do?Quest Diagnostics provides diagnostic testing services to approximately one-third of the US adult population annually,...
Quest Diagnostics provides diagnostic testing services to approximately one-third of the US adult population annually, serving physicians, hospitals, patients, health plans, and employers. Generated $11.0B in revenue in 2025 from clinical lab testing and related services.